mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-06 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
0.31 |
3e-06 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.29 |
4e-06 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
5e-06 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
4e-05 |